Central Sleep Apnea in Cardiovascular Diseases

Area of Science:

• Cardiology
• Sleep Medicine
• Respiratory Medicine

Background:

• Central sleep apnea (CSA) is often linked to cardiovascular diseases (CVDs).
• Commonly associated CVDs include heart failure, atrial fibrillation, and stroke.
• CSA pathophysiology involves a drop in arterial carbon dioxide below the apnea threshold during sleep.

Purpose of the Study:

• To provide an overview of central sleep apnea (CSA) in patients with cardiovascular diseases (CVDs).
• To focus on the clinical aspects, epidemiology, prognosis, and treatment of CSA in the context of CVDs.

Main Methods:

• Literature review and synthesis of existing research on CSA and CVDs.
• Focus on clinical presentation, epidemiological data, prognostic implications, and therapeutic strategies.

Main Results:

• CSA is prevalent in patients with heart failure, atrial fibrillation, and cerebrovascular accidents.
• Patients with CSA in CVD are typically normocapnic or hypocapnic, not hypercapnic.
• CSA significantly impacts the prognosis of cardiovascular conditions.

Conclusions:

• Central sleep apnea is a significant clinical issue in cardiovascular disease management.
• Understanding the epidemiology, presentation, and prognostic impact of CSA is crucial.
• Effective treatment approaches for CSA in CVD patients are essential for improving outcomes.